Fresenius Medical Care (NYSE:FMS) reported quarterly earnings results on February 24, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.84, beating the consensus estimate of $0.67 by $0.17 per share. Revenue came in at $5.9B, beating the estimate of $5.9B.
Fresenius Medical Care's stock moved following the earnings release. The stock currently trades at $22.67 with a market capitalization of $13.7B.